Back to portfolio

Arzeda Corporation

Protein design, pathway design, HT screening and strain construction to create and improve designer fermentation strains for a multitude of chemicals

Arzeda's unique combination of computational protein design and state-of-the-art high-throughput screening is a radical change over what's possible with traditional protein engineering. The Company's proprietary technology has been peer-reviewed in Science and Nature, and is based on solid and vetted models of protein biophysics and metabolic biochemistry coupled with large-scale computing.

Area
Life Sciences
Location
Seattle
Investment year
2020
Organization type
For-profit
Status
Active